Muhammad Umair Mushtaq/LinkedIn
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Muhammad Umair Mushtaq, Associate Professor of Medicine at University of Kansas Medical Center, shared a post on LinkedIn:
“Allogeneic hematopoietic stem cell transplantation can be done in elderly myelofibrosis patients with over 50% two-year survival. Careful patient selection is critical.”
Proceed to the video attached to the post.
More posts featuring Muhammad Umair Mushtaq.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 12, 2025, 06:44
Mar 12, 2025, 06:40
Mar 12, 2025, 06:35
Mar 12, 2025, 06:33
Mar 12, 2025, 06:29
Mar 12, 2025, 06:22
Mar 12, 2025, 06:22
Mar 12, 2025, 06:18
Mar 12, 2025, 06:16
Mar 12, 2025, 06:06
Mar 12, 2025, 06:04